ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Life sciences leaders discuss the future of commercialization at Indegene Digital Summit | September 21-22, 2023 | Virtual-only

PRINCETON, N.J., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced the fifth edition of Indegene Digital Summit, the annual flagship event for global life sciences leaders, on September 21 - 22, 2023. This exclusive thought leadership virtual event will see thought-provoking strategic discussions pertinent to the commercialization functions of the life sciences value chain.

The summit brings a power-packed lineup of thought leaders from within and beyond the life sciences industry on a single platform to exchange views on the future of commercialization. The leaders will discuss the role of technology paradigms such as Generative AI in transforming traditional commercialization models. They will also address a wide range of topics like launch excellence, technology transformation, precision marketing at scale, and customer experience (CX) transformation.

Click here for the agenda and speaker information: https://digitalsummit.indegene.com/
The event is free from vendors or booths.

Keynote speakers include renowned industry leaders:

  • Peter Schnack, Head of Data, Digital & Technology, SVP, Global Portfolio Division, Takeda
  • Juanjo Francesch, Global CIO Human Health IT & MD of MSD Technology Center, Merck
  • Matt Anderson, Chief Digital Officer and Managing Director, The Carlyle Group, and
  • Sharon Barber-Lui, CFO & SVP, North America, Teva Pharmaceuticals

“The life sciences industry is at an inflection point, with commercial leaders on the lookout for new and different ways to ensure launch success,” said Gaurav Kapoor, Executive Vice President, Indegene, Inc. “This edition of Indegene Digital Summit brings a good mix of business and technology leaders to exchange thoughts on the future of commercialization and AI-driven transformation.”

Sessions to watch out for:

  1. The future of content in the biopharma industry
  2. Generative AI in Life Sciences - Sorting the hype from the hope!
  3. The new world of omnichannel: Embracing emerging channels and disruptive tech in customer engagement
  4. Breaking silos: Aligning HCP and patient engagement for better Rx and patient outcomes
  5. Elevating MLR review: Commercial Ops', Reviewers', and Regulators' insights on emerging trends

Indegene Digital Summit is a #FutureReadyHealthcare initiative, orchestrated by Indegene. Visit https://digitalsummit.indegene.com/ to register for the free, virtual-only, two-day event. For live updates, follow #FutureReadyHealthcare on LinkedIn.

About Indegene

Indegene is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations be future ready. To learn more, please visit www.indegene.com

For media inquiries, please contact:
Yadunandan K V | yadunandan.kv@indegene.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.